Anti-TR10C/ TNFRSF10C/ CD263 monoclonal antibody

Anti-TR10C/ TNFRSF10C/ CD263 antibody for FACS & in-vivo assay

Target products collectionGo to TNFRSF10C/TNFRSF10C products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1854-Ab-1/ GM-Tg-hg-MP1854-Ab-2Anti-Human TNFRSF10C monoclonal antibodyHuman
GM-Tg-rg-MP1854-Ab-1/ GM-Tg-rg-MP1854-Ab-2Anti-Rat TNFRSF10C monoclonal antibodyRat
GM-Tg-mg-MP1854-Ab-1/ GM-Tg-mg-MP1854-Ab-2Anti-Mouse TNFRSF10C monoclonal antibodyMouse
GM-Tg-cynog-MP1854-Ab-1/ GM-Tg-cynog-MP1854-Ab-2Anti-Cynomolgus/ Rhesus macaque TNFRSF10C monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1854-Ab-1/ GM-Tg-felg-MP1854-Ab-2Anti-Feline TNFRSF10C monoclonal antibodyFeline
GM-Tg-cang-MP1854-Ab-1/ GM-Tg-cang-MP1854-Ab-2Anti-Canine TNFRSF10C monoclonal antibodyCanine
GM-Tg-bovg-MP1854-Ab-1/ GM-Tg-bovg-MP1854-Ab-2Anti-Bovine TNFRSF10C monoclonal antibodyBovine
GM-Tg-equg-MP1854-Ab-1/ GM-Tg-equg-MP1854-Ab-2Anti-Equine TNFRSF10C monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1854-Ab-1/ GM-Tg-hg-MP1854-Ab-2; GM-Tg-rg-MP1854-Ab-1/ GM-Tg-rg-MP1854-Ab-2;
GM-Tg-mg-MP1854-Ab-1/ GM-Tg-mg-MP1854-Ab-2; GM-Tg-cynog-MP1854-Ab-1/ GM-Tg-cynog-MP1854-Ab-2;
GM-Tg-felg-MP1854-Ab-1/ GM-Tg-felg-MP1854-Ab-2; GM-Tg-cang-MP1854-Ab-1/ GM-Tg-cang-MP1854-Ab-2;
GM-Tg-bovg-MP1854-Ab-1/ GM-Tg-bovg-MP1854-Ab-2; GM-Tg-equg-MP1854-Ab-1/ GM-Tg-equg-MP1854-Ab-2
Products NameAnti-TNFRSF10C monoclonal antibody
Formatmab
Target NameTNFRSF10C
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-TNFRSF10C benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species TR10C/ TNFRSF10C/ CD263 VLP (virus-like particle) (Products Developing)
    CytokineGM-Tg-g-MP1854-Ag-1tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain (TNFRSF10C) protein
    ORF Viral VectorpGMLP002252human TNFRSF10C Lentivirus plasmid
    ORF Viral VectorvGMLP002252human TNFRSF10C Lentivirus particle


    Target information

    Target IDGM-MP1854
    Target NameTNFRSF10C
    Gene ID8794,100430035
    Gene Symbol and SynonymsCD263,DCR1,DCR1-TNFR,LIT,TNFRSF10C,TRAIL-R3,TRAILR3,TRID
    Uniprot AccessionO14798
    Uniprot Entry NameTR10C_HUMAN
    Protein Sub-locationTransmembrane Protein
    CategoryCytokine Target
    DiseaseCancer
    Gene EnsemblENSG00000173535
    Target ClassificationTumor-associated antigen (TAA)

    The target: TNFRSF10C, gene name: TNFRSF10C, also named as CD263, DCR1, DCR1-TNFR, LIT, TRAIL-R3, TRAILR3, TRID. The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor contains an extracellular TRAIL-binding domain and a transmembrane domain, but no cytoplasmic death domain. This receptor is not capable of inducing apoptosis, and is thought to function as an antagonistic receptor that protects cells from TRAIL-induced apoptosis. This gene was found to be a p53-regulated DNA damage-inducible gene. The expression of this gene was detected in many normal tissues but not in most cancer cell lines, which may explain the specific sensitivity of cancer cells to the apoptosis-inducing activity of TRAIL. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.